Skip to the page

Data / Medical devices / United States / Utak Laboratories, Inc.

Utak Laboratories, Inc.: FDA-registered device maker in Valencia, CA, United States, 24 510(k) clearances

Utak Laboratories, Inc. is registered with the FDA (registration 2022375) in Valencia, CA, United States. It lists 3 device types. The FDA files 24 510(k) clearances under its listings, the newest dated November 2, 1994. 1 recall event names it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
2022375
Address
25020 Avenue Tibbitts, Valencia, CA, United States, 91355
Owner or operator
UTAK LABORATORIES, I (2022375)
Roles
Manufacturer
First device listed
December 5, 2007
Registered through
2026
Brand names listed
Amoxapine Control, Anticonvulsants Control, Barbiturates Control, Benzodiazepines Control, Caffeine Control, Cardiacs I Control, Cardiacs II Control, Clonazepam Control and more

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
November 2, 1994K943422TRI-LEVEL WHOLE BLOOD LEAD TOXICOLOGY CONTROLDIFSubstantially EquivalentUtak Lab, Inc.accessdata.fda.gov
April 12, 1991K903061UTAK LABORATORIES TOXICOLOGY CONTROLLASSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
October 6, 1988K883147TRACE ELEMENTS SERUM TOXICOLOGY CONTROLJJYSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
November 13, 1986K862419SERUM VANCOMYCIN TOXICOLOGY CONTROLLASSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
November 13, 1986K862418BENZODIAZEPINES TOXICOLOGY CONTROLLASSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
November 5, 1986K862421SERUM CLONAZEPAM TOXICOLOGY CONTROLLASSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
August 4, 1986K862420UTAK-STABBS TOXICOLOGY CONTROLJJYSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
July 28, 1983K831736TRICYCLIC ANTIDEPRESSANTSDIFSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
July 26, 1983K831741FLURAZEPAM TOXICOLOGY CONTROLDIFSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
July 26, 1983K831738CAFFINE TOXICOLOGY CONTROLLASSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
July 26, 1983K831735MAPROTILINELASSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
July 26, 1983K831734AMOXAPINE 8-HYDRO-XYAMOXAPINEDIFSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
July 19, 1983K831737TRICYCLIC ANTIDEPRESSNATS VIDIFSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
July 6, 1983K831740DISOPYRAMIDE N-DESALKYLDISOPYRAMIDEDIFSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
July 6, 1983K831739PENTOBARBITAL TOXICOLOGY CONTROLLASSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
February 4, 1981K810201TOXICOLOGY CONTROLLASSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
May 2, 1980K800888TRICYCLIC ANTIDEPRESSANTS I TX CONTROLDIFSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
April 29, 1980K800889TRICYCLIC ANTIDEPRESSANT II TX CONTROLDIFSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
April 29, 1980K800887HYPNOTICS PLUS SALICYLATE TX CONTROLDIFSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
April 29, 1980K800886HYPNOTICS PLUS ACETAMINOPHEN TX CONTROLDIFSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
April 29, 1980K800885BARBITURATES TOXICOLOGY CONTROLDIFSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
April 29, 1980K800884CARDIACS II TOXICOLOGY CONTROLDIFSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
April 29, 1980K800883CARDIACS I TOXICOLOGY CONTROLDIFSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov
April 29, 1980K800882ANTICONVULSANTS TOXICOLOGY CONTROLDIFSubstantially EquivalentUtak Laboratories, Inc.accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
March 20, 202085660Class IIITerminatedUtak NR Trace Elements Serum Control, 5 ml, REF 66816. The responsible firm on the label is UTAK LABORATORIES, INC., Valencia, CA. Control for in vitro diagnostics.The product has an incorrect reference value for cadmium and an incorrect expected range.accessdata.fda.gov

Compare with other makers

Updated November 2, 1994. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.